Cryptophycins-309, 249 and other cryptophycin analogs: Preclinical efficacy studies with mouse and human tumors

Author： Liang Jian Moore Richard Moher Eric Munroe John Al-awar Rima Hay David Varie David Zhang Tony Aikins James Martinelli Michael Shih Chuan Ray James Gibson Lowell Vasudevan Vasu Polin Lisa White Kathryn Kushner Juiwanna Simpson Chiab Pugh Susan Corbett Thomas

Publisher： Springer Publishing Company

ISSN： 0167-6997

Source： Investigational New Drugs, Vol.23, Iss.3, 2005-06, pp. : 213-224

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Safety, Efficacy and Therapeutic Potential of Histone Deacetylase Inhibitors with Special Reference to Panobinostat in Gastrointestinal Tumors: A Review of Preclinical and Clinical Studies

Current Cancer Drug Targets, Vol. 18, Iss. 8, 2018-10 ,pp. : 720-736

Bentham Science Publishers

Access to resources Recommend Favorite

Studies on Efficacy of a Novel 177Lu-Labeled Porphyrin Derivative in Regression of Tumors in Mouse Model

Current Radiopharmaceuticals, Vol. 4, Iss. 2, 2011-04 ,pp. : 150-160

Bentham Science Publishers

Access to resources Recommend Favorite

Immunotoxins and Other Conjugates: Pre-clinical Studies

Mini Reviews in Medicinal Chemistry, Vol. 4, Iss. 5, 2004-06 ,pp. : 563-583

Bentham Science Publishers

Access to resources Recommend Favorite

Oncolytic Adenovirus: Preclinical and Clinical Studies in Patients with Human Malignant Gliomas

Current Gene Therapy, Vol. 9, Iss. 5, 2009-10 ,pp. : 422-427

Bentham Science Publishers

Access to resources Recommend Favorite

Developments of Glucagon Like Peptide-1 (GLP-1) and Long-acting Analogs in Clinical and Preclinical Studies for Treatment of Type 2 Diabetes

Current Pharmaceutical Biotechnology, Vol. 14, Iss. 9, 2013-10 ,pp. : 835-841

Bentham Science Publishers

Access to resources Recommend Favorite